The cGAS-STING pathway, crucial for innate immunity, drives harmful neuroinflammation in aging and Alzheimer’s, with recent studies highlighting therapeutic challenges and biomarker potential fo...
A groundbreaking study reveals centenarians’ unique chromatin accessibility in immune cells, with ERG reducing cellular senescence and boosting immune resilience, pointing to new epigenetic inte...
An analysis of clonal hematopoiesis, a somatic mosaicism in blood cells linked to aging, cancer, and cardiovascular risks, exploring ethical challenges in screening. Recent studies highlight clonal he...
Recent studies show age-related gut microbiome changes, such as Klebsiella aerogenes overgrowth, increase histamine production, leading to barrier dysfunction and inflammation, raising sepsis risk. In...
A July 2024 study in ‘Nature Aging’ validates p-tau217 blood biomarkers for forecasting Alzheimer’s symptoms within 3-4 years, enhancing early intervention and personalized medicine....
Recent advancements in cellular reprogramming, including significant funding and clinical trials, are transforming anti-aging science by targeting root causes of age-related diseases. Cellular reprogr...
Recent studies validate blood biomarkers like p-tau217 for predicting Alzheimer’s onset within 3-4 years at 94% accuracy, enabling early interventions but raising ethical and socioeconomic conce...
Recent advances in partial cellular reprogramming using OSKM factors show promise in extending healthspan and treating age-related diseases, with biotech firms accelerating towards human trials. New r...
Recent UK Biobank analysis shows healthy dietary patterns can extend lifespan by 1.5-3.0 years, emphasizing diet as a key modifiable factor for longevity and healthspan extension. New data from UK Bio...
A new blood test based on p-tau217 biomarker can predict Alzheimer’s symptom onset in 3-4 years with high accuracy, offering early intervention opportunities. Recent studies validate a p-tau217 ...
